|
Joon H. Kim, Yeon H. Park |
|
(Methylenetetrahydrofolate reductase, thymidilate synthase and dihydropyrimidine dehydrogenase gene polymorphismsin Korean gastric cancer patients: Genomic predictor of clinical response to capecitabine-based chemotherapy) |
Joon H. Kim, Yeon H. Park |
|
|
|
|